SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001513160-14-000049
Filing Date
2014-09-23
Accepted
2014-09-23 16:13:31
Documents
3
Period of Report
2014-11-03
Effectiveness Date
2014-09-23

Document Format Files

Seq Description Document Type Size
1 LION BIOTECHNOLOGIES, INC. PROXY STATEMENT lbioproxy2014.htm DEF 14A 592693
2 SIGNATURE singhsig.jpg GRAPHIC 3833
3 LOGO lionlogo6.jpg GRAPHIC 592382
  Complete submission text file 0001513160-14-000049.txt   1415718
Mailing Address 21900 BURBANK BLVD. THIRD FLOOR WOODLAND HILLS CA 91367
Business Address 21900 BURBANK BLVD. THIRD FLOOR WOODLAND HILLS CA 91367 818-992-3126
Lion Biotechnologies, Inc. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-53127 | Film No.: 141116223
SIC: 2836 Biological Products, (No Diagnostic Substances)